Shawn Guertin Will Join Davida’s BOD Effective September 15

September 8, 2020

Shawn Guertin will join the Davida board of directors, effective Sept. 15.

Shaw Guertin joins the Board with nearly 35 years of health care experience.  Most recently, Mr. Guertin spent eight years at Aetna, Inc., where he served as executive vice president, chief financial officer and chief enterprise risk officer during a period of significant growth driven by acquisitions and expansion into government programs, leading to Aetna’s eventual merger into CVS Health. At Aetna, Mr. Guertin was a key member of the executive leadership team driving the overall strategic direction of the enterprise and leading the development of the financial strategy to help grow the company into a multifaceted, dynamic health care organization.

“We are thrilled to have Shawn’s deep health care and managed care experience as part of our Board to help us continue to develop and execute on our strategy to transform kidney care,” said Javier Rodriguez, CEO of DaVita Inc. “He adds to our deep bench of financial and operational strength.”

“The expertise Shawn has cultivated throughout his career and, most recently at Aetna and CVS Health, will help DaVita continue to grow and lead within the larger health care community,” said Pam Arway, independent chair of the DaVita Inc. Board of Directors.

Mr. Guertin started his career as an actuary for The Travelers, where he held a number of roles over 11 years, eventually becoming part of the leadership of its group health business that was acquired by UnitedHealthcare.  After working for UnitedHealthcare, Guertin joined Coventry Health Care, where he spent 12 years, including serving as chief actuary and chief financial officer.

“DaVita’s commitment to its patients, teammates, partners and to true transformation in health care was part of the inspiration to join this team,” said Mr. Guertin. “I am excited to share my perspectives on managed care, capital planning and strategic direction as DaVita executes on its innovative strategy.”

Mr. Guertin will serve on DaVita’s audit committee. He also holds a position on the TriNet Board of Directors.

With the addition of Mr. Guertin, the DaVita Board is comprised of ten highly qualified directors, with 40% racial/ethnic and 40% gender diversity.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy